Carregant...
Are selective COX 2 inhibitors superior to traditional NSAIDs? : Rofecoxib did not provide unequivocal benefit over traditional NSAIDs
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2002
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1123680/ https://ncbi.nlm.nih.gov/pubmed/12130617 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|